2.065
price down icon3.50%   -0.075
after-market 시간 외 거래: 2.10 0.035 +1.69%
loading

Ventyx Biosciences Inc 주식(VTYX)의 최신 뉴스

pulisher
Jun 18, 2025

Ventyx stock steady as Parkinson’s drug shows biomarker reductions By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Ventyx reports positive outcomes from trial of VTX3232 for Parkinson’s - Yahoo Finance

Jun 18, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences Inc’s Mixed Bag: Down -9.22% in 6 Months, Down 58.21% in 30 Days - investchronicle.com

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences Announces Positive Top-Line Data from - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences Shares Fall After Tier 2 Exploratory Biomarkers Remain Stable in Parkinson's Study - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx reports positive Phase 2a results for Parkinson’s drug - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences Insiders Placed Bullish Bets Worth US$1.26m - Yahoo

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences' Study of VTX3232 Met Safety, Tolerability Objectives - MarketWatch

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx posts mid-stage trial win for Parkinson’s drug (VTYX) - Seeking Alpha

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences stock trades flat despite positive parkinson’s drug trial data - Investing.com Canada

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences Announces Positive Data From Its Phase 2A Trial Evaluating Vtx3232 In Patients With Early-Stage Parkinson'S Disease - marketscreener.com

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences Announces Positive Data From Its Phase 2A Trial Evaluating Vtx3232 In Patients With Early-Stage Parkinson’S Disease - TradingView

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx reports positive Phase 2a results for Parkinson’s drug By Investing.com - Investing.com India

Jun 17, 2025
pulisher
Jun 17, 2025

VTYX Trading Halted as Market Awaits News Update | VTYX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 15, 2025

Piper Sandler maintains $21 target on Ventyx stock By Investing.com - Investing.com Nigeria

Jun 15, 2025
pulisher
Jun 12, 2025

Traders Buy Large Volume of Ventyx Biosciences Call Options (NASDAQ:VTYX) - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Ventyx Biosciences reports annual meeting results By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Ventyx Biosciences reports annual meeting results - Investing.com

Jun 10, 2025
pulisher
Jun 09, 2025

Piper Sandler maintains $21 target on Ventyx stock - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

As Ventyx Approaches Multiple Phase II Readouts, What Could Be Next For The Stock? - RTTNews

Jun 09, 2025
pulisher
Jun 09, 2025

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Shares Sold by Squarepoint Ops LLC - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

Two Sigma Investments LP Has $1.04 Million Stock Position in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Ventyx Biosciences at Jefferies Conference: Strategic Developments in Focus By Investing.com - Investing.com Canada

Jun 06, 2025
pulisher
Jun 01, 2025

Millennium Management LLC Purchases 1,008,760 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Jun 01, 2025
pulisher
May 29, 2025

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Shares Sold by D. E. Shaw & Co. Inc. - Defense World

May 29, 2025
pulisher
May 29, 2025

Northern Trust Corp Buys 19,982 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 29, 2025
pulisher
May 28, 2025

Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Ventyx Biosciences Executives Set for Key Presentation on Autoimmune Drug Pipeline at Jefferies Conference - Stock Titan

May 28, 2025
pulisher
May 28, 2025

BNP Paribas Financial Markets Takes Position in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 28, 2025
pulisher
May 25, 2025

Bank of America Corp DE Has $9.36 Million Holdings in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 25, 2025
pulisher
May 22, 2025

Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews

May 22, 2025
pulisher
May 21, 2025

Spotlight On 3 Penny Stocks With Market Caps Under $500M - simplywall.st

May 21, 2025
pulisher
May 21, 2025

VTYX LAWSUIT ALERT: Levi & Korsinsky Notifies Ventyx Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

May 21, 2025
pulisher
May 19, 2025

Price T Rowe Associates Inc. MD Sells 13,616 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 19, 2025
pulisher
May 17, 2025

Dimensional Fund Advisors LP Makes New $347,000 Investment in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 17, 2025
pulisher
May 13, 2025

Barclays PLC Boosts Stake in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 13, 2025
pulisher
May 11, 2025

VTYX SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Ventyx Biosciences, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

May 11, 2025
pulisher
May 10, 2025

Mariner LLC Sells 8,485 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 10, 2025
pulisher
May 09, 2025

Ventyx Biosciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your RightsVTYX - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Ventyx Biosciences Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

Investors who lost money on Ventyx Biosciences, Inc. (VTYX) should contact Levi & Korsinsky about pending Class ActionVTYX - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Investors who lost money on Ventyx Biosciences, Inc.(VTYX) should contact Levi & Korsinsky about pending Class ActionVTYX - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Lost Money on Ventyx Biosciences, Inc.(VTYX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Shareholders of Ventyx Biosciences, Inc. Should Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your RightsVTYX - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Market Resilience: Ventyx Biosciences Inc (VTYX) Finishes Weak at 1.28, Down -5.88 - DWinneX

May 08, 2025
pulisher
May 08, 2025

Ventyx Biosciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your RightsVTYX - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Shareholders that lost money on Ventyx Biosciences, Inc.(VTYX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ventyx Biosciences, Inc. - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress - The Manila Times

May 08, 2025
pulisher
May 07, 2025

Ratios Uncovered: Breaking Down Ventyx Biosciences Inc (VTYX)’s Trailing Twelve Months Metrics - DWinneX

May 07, 2025
pulisher
May 05, 2025

Class Action Filed Against Ventyx Biosciences, Inc. (VTYX)April 30, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

May 05, 2025
pulisher
May 04, 2025

VTYX SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ventyx Biosciences, Inc. Investors Can Join the Class Action Lawsuit! - ACCESS Newswire

May 04, 2025
pulisher
May 04, 2025

Levi & Korsinsky Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024VTYX - ACCESS Newswire

May 04, 2025
pulisher
May 04, 2025

Class Action Filed Against Ventyx Biosciences, Inc. (VTYX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

May 04, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):